XG Sciences Announces $4M Agreement with Cabot Corporation

XG Sciences, Inc. announced today that it has finalized an agreement with Cabot Corporation to license certain XG Sciences intellectual property. Under the agreement, XG Sciences will provide Cabot with non-exclusive rights to XG Sciences’ low-cost production technology for the manufacture of Graphene Nanoplatelets. XG Sciences also agrees to sell Cabot certain of XG Sciences’… Read More